A simpler score based on inflammation and nutrition, which includes CRP and albumin, the GPS, has shown prognostic value in patients with DLBCL [22, 64, 65] superior to other inflammation-based prognostic scores [65]. This evidence concerns the gene ALB and diffuse large B-cell lymphoma.